跳至主要内容
临床试验/NCT01736111
NCT01736111已完成不适用

Text Messaging for Weight Loss in Primary Care Patients

The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
91
试验地点
2
主要终点
Change in weight from baseline

研究概览

简要总结

Overweight and obese adults recruited from the primary care setting (n=150) will be enrolled in a 6-month randomized trial of the INTERVENTION versus CONTROL. Both groups will receive usual medical care, printed materials, and educational text messages. The INTERVENTION group will also receive personalized coaching and feedback, as well as peer support, via text message.

The investigators hypothesize that compared to those in the Control group, patients in the Intervention group will lose more weight and demonstrate more favorable changes in fruit and vegetable intake, exercise, and social support for weight loss.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Approved to participate by PCP (Patients with diabetes, hypertension, or dyslipidemia will be eligible if approved by their PCP)
  • Age ≥ 21 years
  • Body mass index (BMI) 25 to 45 kg/m2 and weight ≤ 400 pounds
  • Goal of losing weight (not just maintain weight)
  • Willing to change diet, physical activity in order to lose weight.
  • Currently uses text messaging in English on mobile phone
  • Willing to use send and receive text messages for this study without direct compensation for cost of messages (general compensation for study participation will be provided)
  • Have a scale at home for self-monitoring weight
  • Fluent in English (speak, read, write)
  • Commit to return for follow-up weight at 6 months regardless of amount of weight lost

排除标准

  • Involuntary or voluntary weight loss of ≥ 5% body weight in previous 6 months
  • Participating in research project involving weight loss, exercise, or dietary modification in the previous 6 months
  • Any of the following medical conditions which could affect weight or for which weight loss is contraindicated
  • End-stage liver disease
  • End-stage kidney disease
  • Cancer within previous 2 years (except non-melanoma skin cancer)
  • Myocardial infarction, stroke, or transient ischemic attack within previous 6 months
  • Unstable angina
  • Severe arthritis or other medical conditions which would prevent brisk walking
  • Schizophrenia
  • Hospitalization for psychiatric problems during the prior 12 months.
  • Current use or anticipated future use (during 6 month study) of medications that could cause weight loss:
  • phentermine
  • orlistat (prescription Xenical or OTC Alli)
  • topiramate
  • buprioprion
  • exenatide (Byetta)
  • liraglutide (Victoza)
  • Prior bariatric surgery or plans for bariatric surgery in next 6 months
  • Pregnant or breast feeding within the previous 6 months
  • Planning to become pregnant in next 6 months
  • Consumes > 14 alcoholic drinks per week
  • Current use of illicit drugs
  • Planning to move out of the area in the next 6 months
  • Another member of household or a close contact is participating in the study

结局指标

主要结局

Change in weight from baseline

时间窗: baseline and 6 months

Weight in a lightweight hospital gown with no shoes (calibrated digital scale)

次要结局

  • Change in diet measured by Fruit and Vegetable Screener (NCI)(baseline and 6 months)
  • Change in physical activity as measured by Paffenbarger physical activity questionnaire(baseline and 6 months)
  • Change in executive function as measured by Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A)(baseline and 6 months)
  • Change in social support as measured by Weight Management Support Inventory(baseline and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kevin Hwang, MD

Assistant Professor - Internal Medicine

The University of Texas Health Science Center, Houston

研究点 (2)

Loading locations...

相似试验

Text Messaging for Weight Loss | 临床试验